Neoadjuvant therapy for esophageal cancer
Breast Cancer Update
W.Y. Lau Department of Surgery The Chinese University of Hong Kong.
A.DELENS, MEDICAL STUDENT J.M. WEERTS, FRCS Eng, JM.DEWANDRE, D. FRANCART, C. JEHAES, B. MONAMI. C. WHALEN, S. MARKIEWICZ ABDOMINAL SURGERY, CHC LIEGE.
Esophageal Cancer Approx. 13,000 cases/year in USA Post-esophagectomy overall 5 yr survival = 18% – At presentation, 57% patients are Stage 3, with a 10%
Probing Your Prostate Health: What Every Man Should Know Prostate Cancer Douglas S. Scherr, M.D. Clinical Director, Urologic Oncology Weill Medical College.
Joint Hospital Surgical Grand Round Tsui Tsun Miu NDH.
IN THE NAME OF GOD. Outcomes after resection of locally advanced or borderline resectable pancreatic cancer after neoadjuvant therapy The American Journal.
Andrés Cervantes Stefano Cascinu Clinica di Oncologia Medica Universit à Politecnica delle Marche Ancona Adjuvant or neoadjuvant therapy?
Komen Research Grants Fiscal Year 2009
Types of Biomarkers
Soft Tissue Sarcomas
